Lexicon Pharmaceuticals LXRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $21.1M+1,572% | $5.49M-79.3% | $14.18M+710% | $28.87M+1,653% | $1.26M+11.7% | ||
| $108K+260% | $201K-42.2% | $10K-85.9% | $33K-80.1% | $30K-3.2% | ||
| $20.99M+1,604% | $5.29M-79.8% | $14.17M+744% | $28.83M+1,847% | $1.23M+12.1% | ||
| 99.5%+1.9pp | 96.3%-2.3pp | 99.9%+4.0pp | 99.9%+10.0pp | 97.6%+0.4pp | ||
| $12.76M-16.6% | $11.32M-57.6% | $18.76M-27.2% | $15.75M-10.7% | $15.3M+6.5% | ||
| $9.23M-20.5% | $8.76M-72.9% | $7.6M-80.8% | $9.35M-76.1% | $11.61M-63.8% | ||
| $22.1M-18.0% | $20.27M-65.8% | $26.37M-59.7% | $25.13M-55.9% | $26.94M-42.0% | ||
| -$996K+96.1% | -$14.78M+54.9% | -$12.19M+80.9% | $3.74M+107% | -$25.68M+43.4% | ||
| -4.7%+2,030pp | -269.1%-146pp | -85.9%+3,554pp | 12.9%+3,374pp | -2,034.8%+1,977pp | ||
| $1.48M-50.2% | $1.69M-46.1% | $1.76M-46.5% | $1.92M-41.0% | $2.97M-8.9% | ||
| $1.54M-30.5% | $1.28M-54.7% | $1.57M-54.3% | $1.83M-55.7% | $2.22M+17.8% | ||
| —— | —— | —— | —— | —— | ||
| -$1.04M+95.9% | -$15.53M+54.0% | -$12.77M+80.3% | $3.25M+106% | -$25.3M+47.7% | ||
| -4.9%+1,999pp | -282.7%-156pp | -90%+3,613pp | 11.3%+3,255pp | -2,004.4%+2,279pp | ||
| $0.00+100% | -$0.04+55.6% | -$0.04+77.8% | $0.01+106% | -$0.07+65.0% | ||
| -$886K+96.5% | -$14.66M+55.0% | -$12.04M+81.1% | $3.91M+107% | -$25.5M+43.6% | ||
| -4.2%+2,017pp | -266.9%-144pp | -84.9%+3,548pp | 13.6%+3,366pp | -2,020.8%+1,978pp | ||
| -$996K+96.1% | -$14.78M+54.9% | -$12.19M+80.9% | $3.74M+107% | -$25.68M+43.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lexicon Pharmaceuticals's revenue?
- Lexicon Pharmaceuticals (LXRX) generated $69.6M in revenue over the trailing twelve months, up 123.1% year over year.
- Is Lexicon Pharmaceuticals profitable?
- Lexicon Pharmaceuticals is not currently profitable: it reported a net loss of $26.1M over the trailing twelve months, a -37.5% net margin.
- What are Lexicon Pharmaceuticals's profit margins?
- Gross margin is 99.5% and operating margin is -34.8%, with a -37.5% net margin.
- What is Lexicon Pharmaceuticals's earnings per share?
- Lexicon Pharmaceuticals's diluted EPS over the trailing twelve months is $-0.07.
- Where does Lexicon Pharmaceuticals's income statement data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
